日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial

一项随机、多中心、安慰剂对照的3期临床试验结果显示,新型血小板生成素受体激动剂海曲波帕治疗儿童和青少年免疫性血小板减少症的疗效和安全性

Wu, Runhui; Gao, Ju; Liu, Yufeng; Yu, Jie; Hu, Shaoyan; Liang, Hui; Jiang, Hui; Zhai, Xiaowen; Zhou, Min; Hao, Wenge; Mei, Heng; Li, Fei; Chen, Yumei; Liu, Wei; Yan, Mei; Li, Runzi; Xiong, Junye; Zhu, Zhenyi; Cheng, Xiaoling; Wang, Tianyou

Evaluation of the impact of cardiopulmonary rehabilitation exercise training on cardiopulmonary function in patients with chronic obstructive pulmonary disease complicated by unstable angina pectoris using a hierarchical deep learning CT image model

利用分层深度学习CT图像模型评估心肺康复运动训练对合并不稳定型心绞痛的慢性阻塞性肺疾病患者心肺功能的影响

Xing, Kongyu; Tan, Chunmiao; Cheng, Xiaoling; Jiang, Fen

Optimizing pediatric ITP therapy: a real-world study on plasma concentration-guided eltrombopag dosing

优化儿童ITP治疗:基于血浆浓度指导的艾曲波帕给药的真实世界研究

Li, Jia; Liu, Bo; Wang, Nan; Dong, Shuyue; Ma, Jingyao; Wang, Xiaoling; Guo, Peng; Wu, Runhui; Cheng, Xiaoling

The establishment of an expected concentration reference range for eltrombopag in the individualized treatment of pediatric immune thrombocytopenia

建立艾曲波帕在儿童免疫性血小板减少症个体化治疗中的预期浓度参考范围

Wang, Nan; Dong, Shuyue; Sun, Yixin; Liu, Jingjing; Wang, Zhifa; Ma, Jingyao; Wang, Xiaoling; Wu, Runhui; Cheng, Xiaoling

Agarwood Chromone Alleviates Gastric Ulcers by Inhibiting the NF-κB and Caspase Pathways Based on Network Pharmacology and Molecular Docking.

基于网络药理学和分子对接,沉香色酮通过抑制 NF-κB 和 Caspase 通路缓解胃溃疡

Wang Canhong, Wu Yulan, Gong Bao, Mou Junyu, Cheng Xiaoling, Zhang Ling, Wei Jianhe

Hypoglycaemia episodes in older diabetic adults undergoing haemodialysis

接受血液透析的老年糖尿病患者发生低血糖症

Li, Jinzhu; Ao, Qiangguo; Zhang, Ruiqin; Cheng, Xiaoling; Meng, Xiaomin; Zhang, Xian; Li, Mingxu; Zhao, Jun; Chen, Fengkun; Yan, Shanshan; Fang, Rong; Cheng, Qingli; Ma, Yanlan; Yang, Guang

Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from China

一项来自中国的多中心前瞻性研究表明,对于重度持续性/慢性免疫性血小板减少症,阶梯式反应指导治疗方案优于基于血小板生成素受体激动剂的二线治疗方案:

Fu, Lingling; Lin, Xi; Chen, Zhenping; Wang, Zhifa; Liu, Yan; Wang, Lijuan; Hu, Yu; Ma, Jingyao; Wang, Nan; Cheng, Xiaoling; Ma, Jie; Wu, Runhui

Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort study

利妥昔单抗一线治疗与艾曲波帕单药治疗一线治疗后儿童持续性/慢性免疫难治性血小板减少症的疗效比较:一项前瞻性多中心队列研究

Ma, Jingyao; Wang, Zhifa; Ouyang, Juntao; Lin, Zheyan; Fu, Lingling; Chen, Zhenping; Liu, Yan; Wang, Lijuan; Lin, Xi; Cheng, Xiaoling; Hu, Yu; Dong, Shuyue; Meng, Jinxi; Ma, Jie; Wu, Runhui

Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial

一项多中心随机临床试验表明,与低剂量相比,中等剂量免疫耐受诱导疗法具有起效更快、出血更少且不增加成本的优势。

Li, Zhengping; Li, Zekun; Cheng, Xiaoling; Zhang, Heng; Yang, Can; Xu, Qian; Chen, Zhenping; Zhen, Yingzi; Li, Gang; Liu, Guoqing; Yao, Wanru; Zhou, Min; Jin, Jiao; Huang, Jie; Fang, Yongjun; Xie, Liangzhi; Poon, Man-Chiu; Wu, Runhui

A real-world study of sirolimus in the treatment of pediatric head and neck lymphatic malformations

西罗莫司治疗儿童头颈部淋巴管畸形的真实世界研究

Wang, Jialu; Meng, Yiran; Zhang, Xuexi; Li, Yanzhen; Sun, Nian; Liu, Qiaoyin; Peng, Yun; Cheng, Xiaoling; Liu, Yuanhu; Liu, Zhiyong; Liu, Yuwei; Zhang, Ge; Ni, Xin; Wang, Shengcai